MitoCarta3. 0: an updated mitochondrial proteome now with sub-organelle localization and pathway annotations
…, SH Kim, AV Kotrys, SS Lam, JG McCoy… - Nucleic acids …, 2021 - academic.oup.com
The mammalian mitochondrial proteome is under dual genomic control, with 99% of
proteins encoded by the nuclear genome and 13 originating from the mitochondrial DNA (mtDNA). …
proteins encoded by the nuclear genome and 13 originating from the mitochondrial DNA (mtDNA). …
[PDF][PDF] Standard chemotherapy compared with high-dose chemoradiotherapy for multiple myeloma: final results of phase III US Intergroup Trial S9321
…, PR Greipp, HM Lazarus, DD Hurd, J McCoy… - J Clin Oncol, 2006 - academia.edu
Purpose Results of a prospective randomized trial conducted by the Intergroupe Francais
du Myé lome (IFM 90) indicated that autologous hematopoietic cell–supported high-dose …
du Myé lome (IFM 90) indicated that autologous hematopoietic cell–supported high-dose …
[PDF][PDF] Increased epidermal growth factor receptor gene copy number detected by fluorescence in situ hybridization associates with increased sensitivity to gefitinib in …
FR Hirsch, M Varella-Garcia, J McCoy, H West… - J clin oncol, 2005 - academia.edu
Purpose Bronchioloalveolar carcinoma (BAC) and adenocarcinomas with BAC features seem
to be increasing in incidence, particularly in younger, never-smoking women. Epidermal …
to be increasing in incidence, particularly in younger, never-smoking women. Epidermal …
International prognostic scoring system for Waldenström macroglobulinemia
…, MV Dhodapkar, J McCoy… - Blood, The Journal …, 2009 - ashpublications.org
Recently, many new drugs have been developed for the treatment of Waldenström
macroglobulinemia (WM). To optimize the treatment according to the prognosis and to facilitate the …
macroglobulinemia (WM). To optimize the treatment according to the prognosis and to facilitate the …
X-ray structure of a mammalian stearoyl-CoA desaturase
Stearoyl-CoA desaturase (SCD) is conserved in all eukaryotes and introduces the first double
bond into saturated fatty acyl-CoAs 1 , 2 , 3 , 4 . Because the monounsaturated products of …
bond into saturated fatty acyl-CoAs 1 , 2 , 3 , 4 . Because the monounsaturated products of …
Structure and mechanism of mouse cysteine dioxygenase
JG McCoy, LJ Bailey, E Bitto… - Proceedings of the …, 2006 - National Acad Sciences
Cysteine dioxygenase (CDO) catalyzes the oxidation of l-cysteine to cysteine sulfinic acid.
Deficiencies in this enzyme have been linked to autoimmune diseases and neurological …
Deficiencies in this enzyme have been linked to autoimmune diseases and neurological …
Inhibition of human pancreatic ribonuclease by the human ribonuclease inhibitor protein
RJ Johnson, JG McCoy, CA Bingman… - Journal of molecular …, 2007 - Elsevier
The ribonuclease inhibitor protein (RI) binds to members of the bovine pancreatic ribonuclease
(RNase A) superfamily with an affinity in the femtomolar range. Here, we report on …
(RNase A) superfamily with an affinity in the femtomolar range. Here, we report on …
Structural basis of the alternating-access mechanism in a bile acid transporter
X Zhou, EJ Levin, Y Pan, JG McCoy, R Sharma… - Nature, 2014 - nature.com
Bile acids are synthesized from cholesterol in hepatocytes and secreted through the biliary
tract into the small intestine, where they aid in absorption of lipids and fat-soluble vitamins. …
tract into the small intestine, where they aid in absorption of lipids and fat-soluble vitamins. …
[HTML][HTML] Structural basis for potency differences between GDF8 and GDF11
Background Growth/differentiation factor 8 (GDF8) and GDF11 are two highly similar members
of the transforming growth factor β (TGFβ) family. While GDF8 has been recognized as a …
of the transforming growth factor β (TGFβ) family. While GDF8 has been recognized as a …
Phase III trial of paclitaxel plus carboplatin with or without tirapazamine in advanced non–small-cell lung cancer: Southwest Oncology Group Trial S0003
…, JJ Crowley, PN Lara Jr, J McCoy… - Journal of Clinical …, 2005 - ascopubs.org
Purpose Tumor hypoxia confers chemotherapy resistance. Tirapazamine is a cytotoxin that
selectively targets hypoxic cells. We conducted a phase III clinical trial to determine whether …
selectively targets hypoxic cells. We conducted a phase III clinical trial to determine whether …